Evidence map›Paper›PMID 35912174›Full record

ArticleFrontiers in oncology2022

Flavokawain A Reduces Tumor-Initiating Properties and Stemness of Prostate Cancer.

Liankun Song, Merci Mino, Jana Yamak, Vyvyan Nguyen, Derron Lopez, Victor Pham, Ali Fazelpour, Vinh Le, Dongjun Fu, Matthew Tippin and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. A Novel Tri-Hydroxy-Methylated Chalcone Isolated fromInternational journal of molecular sciences · 2023
    Article
  11. Anticancer Potential of Natural Chalcones: In Vitro and In Vivo Evidence.International journal of molecular sciences · 2023
    Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Liankun SongDepartment of Urology, University of California, Irvine, Orang, CA, United States.
Merci MinoDepartment of Urology, University of California, Irvine, Orang, CA, United States.
Jana YamakDepartment of Urology, University of California, Irvine, Orang, CA, United States.
Vyvyan NguyenDepartment of Urology, University of California, Irvine, Orang, CA, United States.
Derron LopezDepartment of Urology, University of California, Irvine, Orang, CA, United States.
Victor PhamDepartment of Pharmaceutical Sciences, University of California, Irvine, Irvine, CA, United States.
Ali FazelpourDepartment of Urology, University of California, Irvine, Orang, CA, United States.
Vinh LeDepartment of Urology, University of California, Irvine, Orang, CA, United States.
Dongjun FuDepartment of Urology, University of California, Irvine, Orang, CA, United States.
Matthew TippinDepartment of Urology, University of California, Irvine, Orang, CA, United States.
Edward UchioDepartment of Urology, University of California, Irvine, Orang, CA, United States.
Xiaolin ZiDepartment of Urology, University of California, Irvine, Orang, CA, United States.
University of California, Irvine · US

Funding

The NEDD8 pathway mediated Skp2 degradation in chemoprevention by FKAR01CA193967 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI ZI, XIAOLIN · 2016 to 2020
$1.8M
Chemoprevention of urinary bladder carcinogenesis by flavokawain AR01CA122558 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI ZI, XIAOLIN · 2008 to 2012
$1.7M
NCI NIH HHS R01 CA122558NCI NIH HHS R01 CA193967
6 · The paper itself

Abstract

We have previously demonstrated the

Indexed as

cancer stem cellsChemopreventionFlavokawain ANeddylationprostate cancer

Identifiers

PMID35912174
PMCPMC9326116
OpenAlexW4285394212

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.